Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 123 of 151

  1. Sutacimig

    Hemab Therapeutics Holdings

    Congenital Factor VII Deficiency

    phase 2 small molecule active

    1 trial

  2. Sutent®/Sunitinib

    United Therapeutics Europe Ltd

    Neurofibromatosis

    phase 2 small molecule terminated

    1 trial

  3. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Diabetic Peripheral Neuropathy

    phase 2 small molecule completed

    1 trial

  4. SynAct-CS003

    Lacuna Pharma Pty Ltd

    Idiopathic membranous nephropathy and severe proteinuria

    phase 2 small molecule active

    1 trial

  5. SynAct-CS010

    Lacuna Pharma Pty Ltd

    Polymyalgia rheumatica

    phase 2 small molecule active

    1 trial

  6. Systemic chemotherapy (FOLFIRI)

    The First People's Hospital of Lianyungang

    Rectum Cancer

    phase 2 small molecule completed

    1 trial

  7. T2214

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  8. TACE and HAIC Combined With Regorafenib

    The First People's Hospital of Lianyungang

    Liver Metastasis Colon Cancer

    phase 2 other completed

    1 trial

  9. TACE with adebrelimab and bevacizumab

    The First People's Hospital of Lianyungang

    Adebrelimab

    phase 2 small molecule active

    1 trial

  10. TACHIPIRINA compresse for Chronic low back pain

    Dompe' Farmaceutici S.p.A.

    Chronic low back pain

    phase 2 small molecule active

    1 trial

  11. TAK-007

    Takeda

    Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

    phase 2 mab active

    1 trial

  12. TAK-018

    Takeda

    Crohn Disease

    phase 2 small molecule terminated

    1 trial

  13. TAK-019

    Takeda

    Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

    phase 2 mab completed

    1 trial

  14. TAK-041

    NEUROCRINE BIOSCIENCES INC

    Stable Schizophrenia

    phase 2 small molecule completed

    1 trial

  15. TAK-062

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial

  16. TAK-063 20 mg

    Takeda

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  17. TAK-071

    Takeda

    Parkinson Disease

    phase 2 small molecule completed

    1 trial

  18. TAK-079

    Takeda

    Myasthenia Gravis

    phase 2 small molecule completed

    1 trial

  19. TAK-128

    Takeda

    Diabetic Neuropathies

    phase 2 small molecule terminated

    2 trials

  20. TAK-186

    Takeda

    Squamous Cell Cancer of Head and Neck (SCCHN)

    phase 2 small molecule terminated

    1 trial

  21. TAK-188

    Takeda

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule active

    1 trial

  22. TAK-226

    Takeda

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  23. TAK-272

    Takeda

    Type 2 Diabetes Mellitus and Microalbuminuria

    phase 2 small molecule completed

    1 trial

  24. TAK-279

    Takeda

    Crohn's Disease

    phase 2 small molecule active

    1 trial

  25. TAK-279

    Takeda

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  26. TAK-279-CD-2001

    Takeda

    Moderately to Severely Active Crohn's Disease

    phase 2 small molecule active

    1 trial

  27. TAK-279-UC-2001

    Takeda

    Moderate to Severely Active Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  28. TAK-279-VT-2001

    Takeda

    Non-segmental vitiligo

    phase 2 small molecule active

    1 trial

  29. TAK-280

    Takeda

    Unresectable Locally Advanced or Metastatic Cancer

    phase 2 small molecule terminated

    1 trial

  30. TAK-280-1501

    Takeda

    Unresectable Locally Advanced or Metastatic Cancer

    phase 2 small molecule active

    1 trial

  31. TAK-341

    Takeda

    Multiple System Atrophy

    phase 2 small molecule completed

    1 trial

  32. TAK-341-2001

    Takeda

    Multiple System Atrophy

    phase 2 small molecule active

    1 trial

  33. TAK-360

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule active

    1 trial

  34. TAK-360

    Takeda

    Idiopathic Hypersomnia

    phase 2 small molecule active

    1 trial

  35. TAK-360-2001

    Takeda

    Narcolepsy without Cataplexy (NT2)

    phase 2 other active

    1 trial

  36. TAK-360-2002

    Takeda

    Idiopathic Hypersomnia (IH)

    phase 2 other active

    1 trial

  37. TAK-379

    Takeda

    Diabetes Mellitus

    phase 2 small molecule terminated

    1 trial

  38. TAK-385

    Takeda

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  39. TAK-385

    Takeda

    Uterine Fibroids

    phase 2 small molecule completed

    1 trial

  40. TAK-390MR_204

    Takeda

    Symptomatic nonerosive GERD in paediatric subjects aged 2 to 11 years

    phase 2 small molecule active

    1 trial

  41. TAK-390MR_205

    Takeda

    Erosive Esophagitis

    phase 2 small molecule active

    1 trial

  42. TAK-411

    Takeda

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

    phase 2 mab active

    1 trial

  43. TAK-442

    Takeda

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial

  44. TAK-442

    Takeda

    Acute Coronary Syndrome

    phase 2 small molecule completed

    1 trial

  45. TAK-448

    Takeda

    Low Testosterone

    phase 2 small molecule terminated

    1 trial

  46. TAK-448

    Takeda

    Hypogonadotropic Hypogonadism

    phase 2 small molecule terminated

    1 trial

  47. TAK-500

    Takeda

    Pancreatic Cancer

    phase 2 small molecule terminated

    1 trial

  48. TAK-505

    Takeda

    Malignant Solid Tumors

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.